Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DURVALUMAB vs ECALLANTIDE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DURVALUMAB vs ECALLANTIDE: Safety Overview

Metric DURVALUMAB ECALLANTIDE
Total FAERS Reports 17,142 1,206
Deaths Reported 5,088 23
Death Rate 29.7% 1.9%
Hospitalizations 5,968 499
Average Patient Age 65.7 yrs 42.9 yrs
% Female Patients 35.1% 84.1%
Manufacturer AstraZeneca Pharmaceuticals LP Takeda Pharmaceuticals America, Inc.
Route INTRAVENOUS SUBCUTANEOUS
Marketing Status Prescription Prescription